Agrivida, Inc.

Agrivida, Inc. develops innovative agricultural solutions through its GRAINZYME® technology, enhancing livestock nutrition by integrating enzyme production within seed kernels, primarily corn, to improve feed efficiency and reduce environmental waste. Founded in 2003 and headquartered in Woburn, US, Agrivida specializes in agricultural biotechnology, particularly focusing on enzyme-enhanced nutritional solutions for livestock. The company was co-founded by Jeremy Johnson and R Raab, with Mark Wong serving as CEO.

Agrivida has successfully raised a total of USD 3. 914 mn through multiple funding rounds, with the most recent funding being a Series F round led by Open Prairie on January 10, 2023. This marked a pivotal point for the company as it transitioned ownership to Novus International, Inc. Agrivida specializes in the development of GRAINZYME® technology, integrating enzyme production directly within the seed kernel, particularly corn.

This approach allows enzymes such as phytase to function efficiently in livestock feed, enhancing nutritional absorption and minimizing environmental waste, including phosphorus and nitrogen excretion. Agrivida primarily serves livestock producers in sectors such as poultry, swine, dairy, and beef across North America, Asia, and parts of Europe, addressing the demand for sustainable livestock nutrition solutions. Agrivida generates revenue through direct sales of GRAINZYME®-powered corn to feed mills, which distribute the product to livestock producers. The company operates on a B2B model, forming partnerships with feed manufacturers and wholesalers to facilitate the delivery of their enzyme-enhanced corn, thereby promoting a streamlined supply chain focused on efficiency and sustainability.

This operational model emphasizes the value provided to clients through improved livestock performance and reduced environmental impact. Following the acquisition by Novus International, Inc. in January 2023, Agrivida plans to leverage the new partnership to enhance its product offerings, including potential new developments in GRAINZYME® technology aimed at expanding its efficacy and applications. The company intends to explore further expansion into the Asian and European markets by 2025, targeting regions with increasing demands for sustainable agricultural practices.

The recent funding will support these initiatives, allowing Agrivida to develop and market its innovative solutions effectively.